Dr. Aggrey O. Nyabuti is a motivated, hardworking and committed drug safety consultant pharmacist. He is passionate about research and possesses knowledge and skills in working at public, non-governmental and faith-based health institutions. He is a duly registered and licensed pharmacist in Kenya. He is also an active member of the Pharmaceutical Society of Kenya (PSK) and the International Society of Pharmacovigilance (ISoP).
Dr. Aggrey O. N holds a Bachelor of Pharmacy Degree from the University of Nairobi (2013). After practicing as a hospital pharmacist, he proceeded back to the same institution and pursued a Master of Pharmacy degree in Pharmacoepidemiology and Pharmacovigilance (2020). He also has a Senior Management Course from the Kenya School of Government.
Dr. Aggrey O. N has over seven (7) years’ experience in the pharmacy profession. He currently serves as a pharmacovigilance specialist in Kisii County’s department of health, Kenya. Apart from coaching and mentoring healthcare professionals on the importance of pharmacovigilance, he is involved in the management of key pharmacy activities such as; quantification and forecasting of Health Products and Technologies (HPTs), procurement, drug store management, dispensing, pharmaceutical/ clinical patient care, reporting and documentation as well as record keeping.
Dr. Aggrey O. N exercises a high-attention to detail, ensuring accuracy and consistency in his performance, collaborative teamwork, and on-time completion of tasks. Moreover, he offers interpersonal and communication flexibility. He greatly contributes to the strengthening of the pharmacovigilance activities at his workplace. His ambition, dedication and collaborative teamwork have been key drivers for the personal and professional milestones he has achieved so far.
Project Summary
Core Indicators of Appropriate Drug Use at Public Primary Healthcare Centers in Kisii County, Kenya
Background: Irrational drug use is a global problem. However, the extent of the problem is higher in low-income countries. This study sets out to assess and characterize drug use at the public primary healthcare centers (PPHCCs) in a rural county in Kenya, using the World Health Organization/International Network for the Rational Use of Drugs (WHO/INRUD) core drug use indicators methodology.
Methods: Ten PPHCCs were randomly selected. From each PPHCC, ninety prescriptions from October to December 2018 were sampled and data extracted. Three hundred (30 per PPHCC) patients and ten (1 per PPHCC) dispensers were also observed and interviewed. The WHO/INRUD core drug use indicators were used to assess the patterns of drug use.
Results: The average number of drugs per prescription was 2.9 (SD 0.5) (recommended: 1.6–1.8), and the percentage of drugs prescribed by generic names was 27.7% (recommended: 100%); the percentage of prescriptions with an antibiotic was 84.8% (recommended: 20.0–26.8%), and with an injection prescribed was 24.9% (recommended: 13.4–24.1%). The percentage of prescribed drugs from the Kenya Essential Medicines List was 96.7% (recommended: 100%). The average consultation time was 4.1 min (SD 1.7) (recommended: ≥10 min), the average dispensing time was 131.5 sec (SD 41.5) (recommended: ≥90 sec), the percentage of drugs dispensed was 76.3% (recommended: 100%), the percentage of drugs adequately labeled was 22.6%
(recommended: 100%), and the percentage of patients with the correct knowledge of dispensed drugs was 54.7% (recommended:
100%). Only 20% of the PPHCCs had a copy of KEML available, and 80% of the selected essential drugs assessed were available.
Conclusion: The survey shows irrational drug use practices, particularly polypharmacy, non-generic prescribing, overuse of antibiotics, short consultation time, and inadequacy of drug labeling. Effective programs and activities promoting the rational use of drugs are the key interventions suggested at all the health facilities.
Links
https://www.hindawi.com/journals/aps/2020/3173847/
